Vaccinations begin in Alabama as COVID-19 cases soar
December 15, 2020 GMT
BIRMINGHAM, Ala. (AP) Health care workers and a few others began receiving the first vaccinations against the new coronavirus in Alabama on Tuesday as cases of the illness caused by the virus soared.
Two physicians at Southeast Health in Dothan were the first in the state to receive the vaccine, the Alabama Department of Public Health said. Cullman Regional Medical Center said a longtime nurse, Donna Snow, had received an initial dose of the two-step vaccine a day after the hospital, located north of Birmingham, received its first shipment.
“I’m hopeful that more people are able to take the vaccine so we can begin to see a decline in the number of critically ill patients and families impacted by this disease,” Snow, who works in critical care, said in a statement released by the hospital.
Share:
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research and development experience in academic, government,
in vitro diagnostic and device industry settings.
Dr. Stankovic is currently managing partner at Koliada Consulting, LLC, a firm focused on biotech, medical devices and
in vitro diagnostics. Previously, she was Senior Vice President, World Wide Regional Medical Affairs and Global Health, for Becton, Dickinson and Company (BD). Dr. Stankovic served in senior roles at BD for more than a decade, leading medical affairs and clinical operations for various BD business units.
World War II veteran receives first COVID-19 vaccine in Birmingham
Updated Dec 21, 2020;
Facebook Share
A 94-year-old World War II veteran and prisoner of war received the first COVID-19 vaccine in Birmingham on Tuesday at the VA Medical Center.
Lee Elm Creel of Snowtown rolled up his sleeve to make history as one of the first in the state to receive a vaccine developed by Pfizer that received emergency use authorization on Friday. Hospitals across the state began administering vaccines Tuesday, but the VA was the first in Birmingham to start giving shots.
“It felt about like a flu shot,” said Creel, who waited in the VA for 15 minutes after he received his vaccine so health care workers could watch for reactions. “I feel fine.”
Improper DNA division leads to human developmental disorder: Study ANI | Updated: Dec 15, 2020 10:36 IST
Birmingham [UK], December 15 (ANI): A recent study by University of Alabama at Birmingham describes a rare genetic developmentdisorder that causes dwarfism, small ears, a small brain, missing patella and other skeletal abnormalities in humans.
The research published as a highlighted article in the Journal Genetics used fruit fly model to reveal about Meier-Gorlin syndrome, or MGS, which is a rare genetic developmental disorder like dwarfism other skeletal abnormalities. In severe cases, MGS even results in miscarriages and stillbirths.
Igor Chesnokov, PhD, and his University of Alabama at Birmingham colleagues study this recessive, autosomal disorder in an unusual way by placing mutant human genes into fruit flies. Specifically, they look at one of the genes involved in MGS called Orc6.
Genkyotex: Disclosure of the Total Number of Voting Rights and Shares Pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial Markets Authority
Regulatory News:
Genkyotex shares
Date
(1): 11,736,174
meeting
(2): 11,726,931
(1) In accordance with Article 223-111 of the AMF s General Regulation, this number of shares is calculated based on all shares carrying the right to vote, including those stripped of voting rights.
(2) Less shares stripped of voting rights.
About Genkyotex
Genkyotex is the leading biopharmaceutical company in NOX therapies, listed on the Euronext Paris and Euronext Brussels markets. Its unique platform enables the identification of orally available small-molecules which selectively inhibit specific NOX enzymes that amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. Genkyotex is developing a pipeline